Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus (NCT07527650)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Subjects With Type 2 Diabetes Mellitus
🩺 Plain-English Summary (8th-Grade Level)
This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.
Who can join: Review the eligibility criteria below.
Location: Desert Clinical Research — Mesa, Arizona
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- Desert Clinical Research — Mesa, Arizona
- Accel Research Sites - DeLand — DeLand, Florida
- Charter Research — Orlando, Florida
- AdventHealth Translational Research Institute — Orlando, Florida
- K2 Medical Research The Villages LLC — The Villages, Florida
- Centricity Research IRT - DBA IACT Health Columbus Piedmont — Columbus, Georgia
- The South Bend Clinic — South Bend, Indiana
- Jefferson City Medical Center — Jefferson City, Missouri
- Clay Platte Family Medicine — Kansas City, Missouri
- Methodist Physicians Clinic — Fremont, Nebraska
- Santa Rosa Medical Centers of Nevada — Las Vegas, Nevada
- Lucas Research, Inc. — Morehead City, North Carolina
- Centricity Research Columbus — Columbus, Ohio
- Olympus Family Medicine — Salt Lake City, Utah
- Manassas Clinical Research Center — Manassas, Virginia
📞 Contact the Study Coordinator
Phone: (822) 410-9147
Email: pureun.nam@hanmi.co.kr
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes Mellitus
- Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study — Aurora, Colorado
- A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Tucson, Arizona
- Preventing Type 2 Diabetes in Black Emergent Adult — Chapel Hill, North Carolina
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — Birmingham, Alabama
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Huntsville, Alabama
- GLP-1 and Hypoglycemia — Baltimore, Maryland
Explore by condition: All Type 2 Diabetes Mellitus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.